Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial

Title
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
Authors
Keywords
Anticoagulant, Bleeding, Death, Edoxaban, Factor Xa inhibitor, Hemorrhage, Warfarin
Journal
AMERICAN JOURNAL OF MEDICINE
Volume 129, Issue 8, Pages 850-857.e2
Publisher
Elsevier BV
Online
2016-03-17
DOI
10.1016/j.amjmed.2016.02.028

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now